{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:09:51Z","timestamp":1788685791482,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10528-026-11389-z","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:46:50Z","timestamp":1778651210000},"page":"7293-7318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circular RNA Circ_0020236 Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration Through Modulating the MiR-1825\/IKBKB Axis"],"prefix":"10.1007","volume":"64","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"4","key":"11389_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-0039-1688442","volume":"39","author":"AY Afify","year":"2019","unstructured":"Afify AY, Ibrahim SA, Aldamsisi MH, Zaghloul MS, El-Ekiaby N, Abdelaziz AI (2019) Competing endogenous rnas in hepatocellular carcinoma-the pinnacle of rivalry. Semin Liver Dis 39(4):463\u2013475","journal-title":"Semin Liver Dis"},{"key":"11389_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semcancer.2018.02.007","volume":"56","author":"N Awasthee","year":"2019","unstructured":"Awasthee N, Rai V, Chava S et al (2019) Targeting ikappaappab kinases for cancer therapy. Semin Cancer Biol 56:12\u201324","journal-title":"Semin Cancer Biol"},{"issue":"23","key":"11389_CR3","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.jacc.2016.09.945","volume":"68","author":"T Barwari","year":"2016","unstructured":"Barwari T, Joshi A, Mayr M (2016) Micrornas in cardiovascular disease. J Am Coll Cardiol 68(23):2577\u20132584","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"11389_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1261\/rna.079585.123","volume":"29","author":"A Bashari","year":"2023","unstructured":"Bashari A, Siegfried Z, Karni R (2023) Targeting splicing factors for cancer therapy. RNA 29(4):506\u2013515","journal-title":"RNA"},{"issue":"10","key":"11389_CR5","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/jcb.30473","volume":"124","author":"O Capik","year":"2023","unstructured":"Capik O, Gundogdu B, Tatar A, Sahin A, Chen F, Creighton CJ, Karatas OF (2023) Oncogenic mir-1825 promotes head and neck carcinogenesis via targeting frem1. J Cell Biochem 124(10):1628\u20131645","journal-title":"J Cell Biochem"},{"key":"11389_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JHC.S268291","volume":"8","author":"A Ely","year":"2021","unstructured":"Ely A, Bloom K, Maepa MB, Arbuthnot P (2021) Recent update on the role of circular rnas in hepatocellular carcinoma. J Hepatocell Carcinoma 8:1\u201317","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"11389_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12943-020-01230-5","volume":"19","author":"L Fan","year":"2020","unstructured":"Fan L, Cao Q, Liu J, Zhang J, Li B (2020) Correction to: circular rna profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis. Mol Cancer 19(1):113","journal-title":"Mol Cancer"},{"issue":"1","key":"11389_CR8","first-page":"1","volume":"16","author":"Y Ghouri","year":"2017","unstructured":"Ghouri Y, Mian I, Rowe J (2017) Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog 16(1):1","journal-title":"J Carcinog"},{"issue":"2","key":"11389_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ncrna.2022.12.006","volume":"8","author":"M Hassan","year":"2022","unstructured":"Hassan M, Nasr SM, Amin NA, El-Ahwany E, Zoheiry M, Elzallat M (2022) Circulating liver cancer stem cells and their stemness-associated micrornas as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma. Noncoding RNA Res 8(2):155\u2013163","journal-title":"Noncoding RNA Res"},{"issue":"2","key":"11389_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ncrna.2022.12.006","volume":"8","author":"M Hassan","year":"2023","unstructured":"Hassan M, Nasr SM, Amin NA, El-Ahwany E, Zoheiry M, Elzallat M (2023) Circulating liver cancer stem cells and their stemness-associated micrornas as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma. Noncoding RNA Res 8(2):155\u2013163","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"11389_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M (2011) Nf-kappab and stat3 - key players in liver inflammation and cancer. Cell Res 21(1):159\u2013168","journal-title":"Cell Res"},{"issue":"3","key":"11389_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccr.2009.12.048","volume":"17","author":"G He","year":"2010","unstructured":"He G, Yu GY, Temkin V et al (2010) Hepatocyte ikkbeta\/nf-kappab inhibits tumor promotion and progression by preventing oxidative stress-driven stat3 activation. Cancer Cell 17(3):286\u2013297","journal-title":"Cancer Cell"},{"issue":"3","key":"11389_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jhep.2021.04.033","volume":"75","author":"J Hyun","year":"2021","unstructured":"Hyun J, Al Abo M, Dutta RK et al (2021) Dysregulation of the esrp2-nf2-yap\/taz axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease. J Hepatol 75(3):623\u2013633","journal-title":"J Hepatol"},{"issue":"8","key":"11389_CR14","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3390\/genes13081484","volume":"13","author":"SY Jang","year":"2022","unstructured":"Jang SY, Kim G, Tak WY et al (2022) Circular noncoding rna hsa_circ_0003570 as a prognostic biomarker for hepatocellular carcinoma. Genes (Basel) 13(8):1484","journal-title":"Genes (Basel)"},{"issue":"5","key":"11389_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE (2014) Detecting and characterizing circular rnas. Nat Biotechnol 32(5):453\u2013461","journal-title":"Nat Biotechnol"},{"issue":"22","key":"11389_CR16","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.3390\/cells11223571","volume":"11","author":"L Ju","year":"2022","unstructured":"Ju L, Yao M, Lu R et al (2022) Circular rna hsa_circ_0051040 promotes hepatocellular carcinoma progression by sponging mir-569 and regulating itgav expression. Cells 11(22):3571","journal-title":"Cells"},{"issue":"10","key":"11389_CR17","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/genes14101963","volume":"14","author":"MK Kang","year":"2023","unstructured":"Kang MK, Kim G, Park JG et al (2023) Tissue circular rna_0004018 and 0003570 as novel prognostic biomarkers for hepatitis b-related hepatocellular carcinoma. Genes (Basel) 14(10):1963","journal-title":"Genes (Basel)"},{"issue":"2","key":"11389_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/jcmm.17126","volume":"26","author":"S Khashkhashi Moghadam","year":"2022","unstructured":"Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Mahmud Hussen B, Babashah S (2022) Non-coding RNA-associated competitive endogenous RNA regulatory networks: novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. J Cell Mol Med 26(2):287\u2013305","journal-title":"J Cell Mol Med"},{"issue":"1","key":"11389_CR19","doi-asserted-by":"publisher","first-page":"14930","DOI":"10.1038\/s41598-021-94074-y","volume":"11","author":"G Kim","year":"2021","unstructured":"Kim G, Han JR, Park SY et al (2021) Circular noncoding rna hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma. Sci Rep 11(1):14930","journal-title":"Sci Rep"},{"issue":"5543","key":"11389_CR20","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed rnas. Science 294(5543):853\u2013858","journal-title":"Science"},{"issue":"3","key":"11389_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11684-019-0728-2","volume":"14","author":"A Lee","year":"2020","unstructured":"Lee A, Lee FC (2020) Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check. Front Med 14(3):273\u2013283","journal-title":"Front Med"},{"issue":"8","key":"11389_CR23","doi-asserted-by":"publisher","first-page":"13807","DOI":"10.1002\/jcp.28061","volume":"234","author":"X Li","year":"2019","unstructured":"Li X, Diao H (2019) Circular rna circ_0001946 acts as a competing endogenous rna to inhibit glioblastoma progression by modulating mir-671-5p and cdr1. J Cell Physiol 234(8):13807\u201313819","journal-title":"J Cell Physiol"},{"issue":"8","key":"11389_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C et al (2015) Circular rna is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 25(8):981\u2013984","journal-title":"Cell Res"},{"issue":"2","key":"11389_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s13402-020-00564-y","volume":"44","author":"R Li","year":"2021","unstructured":"Li R, Deng Y, Liang J et al (2021) Circular rna circ-102,166 acts as a sponge of mir-182 and mir-184 to suppress hepatocellular carcinoma proliferation and invasion. Cell Oncol (Dordr) 44(2):279\u2013295","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"11389_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/14728220903431069","volume":"14","author":"Y Lin","year":"2010","unstructured":"Lin Y, Bai L, Chen W, Xu S (2010) The nf-kappab activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets 14(1):45\u201355","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"11389_CR25","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.7150\/thno.49819","volume":"11","author":"L Lin","year":"2021","unstructured":"Lin L, Chen S, Wang H et al (2021) Sptbn1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of socs1 and downregulation of p65 in hepatocellular carcinoma. Theranostics 11(9):4232\u20134250","journal-title":"Theranostics"},{"issue":"21","key":"11389_CR27","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1080\/15384101.2019.1664223","volume":"18","author":"L Liu","year":"2019","unstructured":"Liu L, Yang X, Li NF, Lin L, Luo H (2019) Circ_0015756 promotes proliferation, invasion and migration by microrna-7-dependent inhibition of fak in hepatocellular carcinoma. Cell Cycle 18(21):2939\u20132953","journal-title":"Cell Cycle"},{"issue":"1","key":"11389_CR28","doi-asserted-by":"publisher","first-page":"22058","DOI":"10.1038\/s41598-023-47374-4","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Dong Z, Chen W et al (2023) Construction of a cerna regulatory network to explore potential pathogenesis mechanisms involved in human hepatocellular carcinoma. Sci Rep 13(1):22058","journal-title":"Sci Rep"},{"issue":"12","key":"11389_CR29","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/cells11121948","volume":"11","author":"H Meng","year":"2022","unstructured":"Meng H, Niu R, Huang C, Li J (2022) Circular rna as a novel biomarker and therapeutic target for hcc. Cells 11(12):1948","journal-title":"Cells"},{"issue":"4","key":"11389_CR30","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1093\/nar\/gkv045","volume":"43","author":"S Petkovic","year":"2015","unstructured":"Petkovic S, M\u00fcller S (2015) Rna circularization strategies in vivo and in vitro. Nucleic Acids Res 43(4):2454\u20132465","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"11389_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) Microrna therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203\u2013222","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"11389_CR32","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram KH, Soleymani FS, Ghaffari SH (2019) An overview of micrornas: biology, functions, therapeutics, and analysis methods. J Cell Physiol 234(5):5451\u20135465","journal-title":"J Cell Physiol"},{"issue":"2","key":"11389_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cytogfr.2008.01.006","volume":"19","author":"JA Schmid","year":"2008","unstructured":"Schmid JA, Birbach A (2008) Ikappab kinase beta (IKKbeta\/IKK2\/IKBKB)\u2014a key molecule in signaling to the transcription factor nf-kappab. Cytokine Growth Factor Rev 19(2):157\u2013165","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"11389_CR34","doi-asserted-by":"publisher","first-page":"109168","DOI":"10.1016\/j.isci.2024.109168","volume":"27","author":"J Sun","year":"2024","unstructured":"Sun J, Wu H, Luo J et al (2024) Circtbc1d22a inhibits the progression of colorectal cancer through autophagy regulated via mir-1825\/atg14 axis. iScience 27(3):109168","journal-title":"iScience"},{"issue":"3","key":"11389_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249","journal-title":"Cancer J Clin"},{"issue":"3","key":"11389_CR37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/bib\/bbz032","volume":"21","author":"J Wang","year":"2020","unstructured":"Wang J, Cao Y, Lu X et al (2020) Micrornas and nervous system diseases: network insights and computational challenges. Brief Bioinform 21(3):863\u2013875","journal-title":"Brief Bioinform"},{"issue":"1","key":"11389_CR36","doi-asserted-by":"publisher","first-page":"23890","DOI":"10.1038\/s41598-021-03285-w","volume":"11","author":"G Wang","year":"2021","unstructured":"Wang G, Jiang Y, Lu C, Jiang W, Wu S, Hua Y (2021) Circfoxm1 promotes proliferation and metastasis of hepatocellular carcinoma via regulating mir-1179\/spag5 axis. Sci Rep 11(1):23890","journal-title":"Sci Rep"},{"issue":"1","key":"11389_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13046-021-02062-x","volume":"40","author":"X Xu","year":"2021","unstructured":"Xu X, Lei Y, Chen L et al (2021) Phosphorylation of nf-kappabp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target. J Exp Clin Cancer Res 40(1):253","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"11389_CR39","doi-asserted-by":"publisher","first-page":"e2305653","DOI":"10.1002\/advs.202305653","volume":"11","author":"Q Yan","year":"2024","unstructured":"Yan Q, Fang X, Liu X et al (2024) Loss of esrp2 activates tak1-mapk signaling through the fetal rna-splicing program to promote hepatocellular carcinoma progression. Adv Sci (Weinh) 11(1):e2305653","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"11389_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16(10):589\u2013604","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"11389_CR41","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41467-017-01216-w","volume":"8","author":"CY Yu","year":"2017","unstructured":"Yu CY, Li TC, Wu YY, Yeh CH, Chiang W, Chuang CY, Kuo HC (2017) The circular rna circbirc6 participates in the molecular circuitry controlling human pluripotency. Nat Commun 8(1):1149","journal-title":"Nat Commun"},{"issue":"1","key":"11389_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-018-0914-x","volume":"17","author":"K Zeng","year":"2018","unstructured":"Zeng K, He B, Yang BB et al (2018) The pro-metastasis effect of circanks1b in breast cancer. Mol Cancer 17(1):160","journal-title":"Mol Cancer"},{"issue":"1","key":"11389_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13046-022-02478-z","volume":"41","author":"J Zhang","year":"2022","unstructured":"Zhang J, Pan T, Zhou W et al (2022) Long noncoding rna linc01132 enhances immunosuppression and therapy resistance via nrf1\/dpp4 axis in hepatocellular carcinoma. J Exp Clin Cancer Res 41(1):270","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"11389_CR44","doi-asserted-by":"publisher","first-page":"24580","DOI":"10.1038\/s41598-025-10618-6","volume":"15","author":"K Zhang","year":"2025","unstructured":"Zhang K, Fang T, Chen Q, Yan X, Jin X, Ma N (2025) Circ_0008043 promotes the metastasis of hepatocellular carcinoma by regulating the mir-661\/plekhg4b axis. Sci Rep 15(1):24580","journal-title":"Sci Rep"},{"issue":"3","key":"11389_CR45","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41418-019-0423-5","volume":"27","author":"W Zhao","year":"2020","unstructured":"Zhao W, Cui Y, Liu L et al (2020) Splicing factor derived circular rna circuhrf1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop. Cell Death Differ 27(3):919\u2013933","journal-title":"Cell Death Differ"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-026-11389-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:10:29Z","timestamp":1788682229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-026-11389-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11389"],"URL":"https:\/\/doi.org\/10.1007\/s10528-026-11389-z","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical study was approved by the Ethics Committee of The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine (approval number: K2023-008). This study was performed in line with the principles of the Declaration of Helsinki. The animal study was approved by the Ethics Committee of Guizhou University of Traditional Chinese Medicine (Approval Number: 2024111). All animal experiments should comply with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in figures.","order":4,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}